Symmetrical Dimethylarginine Outperforms CKD-EPI and MDRD-Derived eGFR for the Assessment of Renal Function in Patients with Adult Congenital Heart Disease | Zendy

Oktay Tutarel | Zendy; Agnieszka Denecke | Zendy; Stefanie M. BodeBöger | Zendy; Jens MartensLobenhoffer | Zendy; Bernhard Schieffer | Zendy; Mechthild WesthoffBleck | Zendy; Jan T. Kielstein | Zendy

Open Access

Symmetrical Dimethylarginine Outperforms CKD-EPI and MDRD-Derived eGFR for the Assessment of Renal Function in Patients with Adult Congenital Heart Disease

Author(s) -

Oktay Tutarel,

Agnieszka Denecke,

Stefanie M. BodeBöger,

Jens MartensLobenhoffer,

Bernhard Schieffer,

Mechthild WesthoffBleck,

Jan T. Kielstein

Publication year - 2010

Publication title -

kidney and blood pressure research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.806

H-Index - 51

eISSN - 1423-0143

pISSN - 1420-4096

DOI - 10.1159/000322614

Subject(s) - renal function , cystatin c , medicine , kidney disease , population , urology , endocrinology , disease , cardiology , environmental health

Adults with congenital heart disease exhibit a 3-fold higher mortality in the presence of chronic kidney disease, hence assessment of renal function is crucial in this patient population. Formulas for the estimation of glomerular filtration rate (GFR) have not been evaluated in this patient population. Therefore, this study compares different markers and equations for the estimation of renal function in adults with congenital heart disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research